Posted by Michael Wonder on 30 Nov 2023
Cabozantinib maleate with nivolumab for patients with untreated advanced renal cell carcinoma
30 November 2023 - The Department of Health and Social Care has asked NICE to produce guidance on the use of cabozantinib maleate in combination with nivolumab in the NHS in England.
For the time being, the combination of cabozantinib maleate and nivolumab is not recommended for the first-line treatment of adults with advanced renal cell carcinoma.
